Similar articles for PMID: 26541778

Year	Number of Results
2003	2
2004	11
2005	2
2006	2
2007	7
2008	13
2009	11
2010	9
2011	12
2012	26
2013	24
2014	22
2015	27
2016	27
2017	40
2018	31
2019	24
2020	23
2021	18
2022	14
2023	1
2024	0

1

PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.

Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W. Luo H, et al. J Nucl Med. 2016 Feb;57(2):285-90. doi: 10.2967/jnumed.115.166462. Epub 2015 Nov 5. J Nucl Med. 2016. PMID: 26541778 Free PMC article.

2

A three-time-point method for assessing kinetic parameters of ⁶⁴Cu-labeled Ramucirumab trapping in VEGFR-2 positive lung tumors.

Laffon E, Marthan R. Laffon E, et al. Phys Med. 2017 Nov;43:1-5. doi: 10.1016/j.ejmp.2017.10.001. Epub 2017 Oct 9. Phys Med. 2017. PMID: 29195550

3

ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.

England CG, Jiang D, Hernandez R, Sun H, Valdovinos HF, Ehlerding EB, Engle JW, Yang Y, Huang P, Cai W. England CG, et al. Mol Pharm. 2017 Oct 2;14(10):3239-3247. doi: 10.1021/acs.molpharmaceut.7b00216. Epub 2017 Sep 6. Mol Pharm. 2017. PMID: 28825843 Free PMC article.

4

PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.

Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W. Luo H, et al. J Nucl Med. 2015 May;56(5):758-63. doi: 10.2967/jnumed.115.154690. Epub 2015 Apr 3. J Nucl Med. 2015. PMID: 25840981 Free PMC article.

5

ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.

Sun H, England CG, Hernandez R, Graves SA, Majewski RL, Kamkaew A, Jiang D, Barnhart TE, Yang Y, Cai W. Sun H, et al. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2169-2179. doi: 10.1007/s00259-016-3442-1. Epub 2016 Jun 25. Eur J Nucl Med Mol Imaging. 2016. PMID: 27342417 Free PMC article.

6

PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Jeppesen TE, Kristensen LK, Jensen MM, El Ali HH, Madsen J, Wiinberg B, Petersen LC, Kjaer A. Nielsen CH, et al. J Nucl Med. 2016 Jul;57(7):1112-9. doi: 10.2967/jnumed.115.170266. Epub 2016 Mar 24. J Nucl Med. 2016. PMID: 27013699 Free article.

7

⁶⁴Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors.

Pyo A, Yun M, Kim HS, Kim TY, Lee JJ, Kim JY, Lee S, Kwon SY, Bom HS, Kim HS, Kim DY, Min JJ. Pyo A, et al. J Nucl Med. 2018 Feb;59(2):340-346. doi: 10.2967/jnumed.117.197020. Epub 2017 Sep 15. J Nucl Med. 2018. PMID: 28916621 Free article.

8

In vivo small-animal PET/CT of EphB4 receptors using 64Cu-labeled peptide.

Xiong C, Huang M, Zhang R, Song S, Lu W, Flores L 2nd, Gelovani J, Li C. Xiong C, et al. J Nucl Med. 2011 Feb;52(2):241-8. doi: 10.2967/jnumed.110.081943. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233177 Free article.

9

A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.

Li F, Jiang S, Zu Y, Lee DY, Li Z. Li F, et al. J Nucl Med. 2014 Sep;55(9):1525-31. doi: 10.2967/jnumed.114.138925. Epub 2014 Jun 26. J Nucl Med. 2014. PMID: 24970912 Free article.

10

Immuno-PET of tissue factor in pancreatic cancer.

Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W. Hong H, et al. J Nucl Med. 2012 Nov;53(11):1748-54. doi: 10.2967/jnumed.112.105460. Epub 2012 Sep 17. J Nucl Med. 2012. PMID: 22988057 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

297 results

Results by year